Consumer Reports: Alzheimer's drugs are costly, ineffective

01/8/2013 | Washington Post, The

Drugs approved to treat Alzheimer's disease are expensive and are not really effective for many patients, according to Consumer Reports Best Buy Drugs. The report said none of the drugs could be considered a "Best Buy," based on analyses from several health care organizations, and that they had side effects that could be debilitating for older patients.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA